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Introduction
MicroRNAs (miRNAs) are a class of small noncoding RNAs 
that are processed by Dicer from precursors with a characteristic 
hairpin secondary structure (Ambros et al., 2003). Hundreds of 
miRNAs have been identifi  ed from plants, animals, and viruses 
(miRBase; http://microrna.sanger.ac.uk/sequences/). miRNAs 
are implicated in various cellular processes, such as cell fate 
determination, cell death, and tumorigenesis (for review see 
Bartel, 2004). Many miRNAs are expressed in a tissue-specifi  c 
manner (Lagos-Quintana et al., 2002; Babak et al., 2004; Barad 
et al., 2004; Liu et al., 2004; Sempere et al., 2004; Thomson 
et al., 2004; Baskerville and Bartel, 2005; Wienholds et al., 
2005), suggesting a role of the miRNAs in the specifi  cation of 
the tissue during differentiation.
Among the hundreds of miRNAs, only a small fraction 
have assigned target mRNAs or an established role. Valid target 
prediction is a major problem in the study of miRNAs. Although 
several algorithms for target prediction have been based on se-
quence similarity between targets and miRNAs (Bentwich, 
2005), the small size of the miRNAs and the tolerance for mis-
matches and bulges in the recognition sequence result in most 
of these algorithms’ predicting too many targets.
The mode of action of miRNAs on their targets is contro-
versial. Classic results from lin-4 miRNAs suggested that the 
miRNAs bind to their targets with imperfect complementarity 
and decrease the levels of encoded proteins without decreasing 
the target mRNA (Olsen and Ambros, 1999; Seggerson et al., 
2002). In contrast, target mRNA is cleaved specifi  cally at the 
recognition site by siRNA (Elbashir et al., 2001b), many plant 
miRNAs (for reviews see Kidner and Martienssen, 2005; Millar 
and Waterhouse, 2005), and at least one animal miRNA (Yekta 
et al., 2004). In all cases where the target mRNA is cleaved, the 
interaction between the small RNA and the target mRNA is 
nearly perfect. Therefore, the degree of complementarity has 
been thought to be a major determinant in dictating whether a 
miRNA promotes mRNA degradation or inhibits protein syn-
thesis. Although this hypothesis is supported by mutation ana-
lyses of miRNAs and their target mRNAs (Doench et al., 2003; 
Saxena et al., 2003), a recent report demonstrated that a miRNA 
can regulate the levels of several target mRNAs despite mis-
matches and bulges between the miRNA and the targets (Lim 
et al., 2005). This was shown true for even lin-4 and let-7 
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  miRNAs (Bagga et al., 2005), which had been thought to block 
only the translational step.
Differentiation down a specifi  c lineage is characterized 
by the activation of tissue-specifi  c transcription factors and 
modulation of gene expression. To study the role of miRNA 
in such a process and begin the process of identifying poten-
tial targets, we studied muscle differentiation using the C2C12 
myoblast (MB) cell line as a model system (Yaffe and Saxel, 
1977;  Andres and Walsh, 1996). Upon serum depletion,  muscle-
 specifi  c transcription factors such as myogenin are induced and 
many muscle genes are turned on. Subsequently, cells become 
elongated and fused to each other to form multinucleate myo-
tubes (MTs). Another critical event during the differentiation 
process is a decrease in DNA synthesis and cell cycle arrest. 
We show here that miRNAs miR-206, -1, and -133 on their own 
change the gene expression profi  le of C2C12 toward the dif-
ferentiated state and that miR-206 induces many of the markers 
of differentiation. The miRNAs regulate many target mRNAs 
as revealed by microarray screening. Antisense oligonucleo-
tides to these miRNAs inhibit muscle differentiation and entry 
into cell quiescence. We predicted the putative direct targets 
of miR-206 by intersecting the mRNAs down-regulated in the 
microarray data with the computational prediction of targets 
based on sequence match to the miRNA. As an example of the 
utility of this approach, we identify four mRNAs, including 
that of the largest subunit (p180 subunit; Pola1) of DNA poly-
merase α (DNA pol α) as being directly regulated by miR-206. 
Two of the targets, including DNA pol α, are cleaved at mul-
tiple sites by the miRNA. The effect of miR-206 on DNA pol α, 
thereby DNA synthesis, is a new example of miRNA function 
connecting the cell quiescence event with the differentiation 
process. In addition, inhibitors of myogenic transcription fac-
tors are indirectly down-regulated by miR-206, thereby further 
promoting the differentiation process. Recently, another group 
reported a critical role of miR-1 and -133 in C2C12 differen-
tiation (Chen et al., 2006). Together, we can conclude that all 
three miRNAs induced during C2C12 differentiation are very 
important for myogenesis.
Results
Speciﬁ  c expression of miR-1, -133, 
and -206 during skeletal myogenesis
Previous results suggested that miR-1, -133, and -206 are ex-
pressed in muscle and heart (Lagos-Quintana et al., 2002; 
  Sempere et al., 2004; Zhao et al., 2005; Chen et al., 2006). 
  Consistent with this, RNase protection assays (Fig. 1 A) 
showed that miR-1 and -133 are abundant in skeletal muscle 
and heart and that miR-206 is specifi  cally abundant in skeletal 
muscle. miR-1 and -206 have an 18/21 match in sequence with 
each other and complete identity in the fi  rst eight nucleotides 
(  miRBase) that constitute the seed sequence for target recognition 
(Doench and Sharp, 2004).
C2C12 mouse MBs can be induced to differentiate into 
MTs by serum depletion, as indicated here by the induction of 
myogenin, cell cycle inhibitor p21, and myosin heavy chain 
(MHC) with a constant level of Cdk4 as a loading control 
(Fig. 1 B). miR-1, -133, and -206 were not expressed in undif-
ferentiated C2C12 but were induced during muscle differentiation
(Fig. 1 B; Chen et al., 2006), whereas two other miRNAs (let-7 
and miR-125b) were expressed constantly throughout the dif-
ferentiation process. Using this in vitro differentiation of 
C2C12, we studied whether the miRNAs play an active role 
during skeletal myogenesis.
Role of the muscle-speciﬁ  c miRNAs during 
skeletal myogenesis
To investigate the function of these miRNAs in myogenesis, 
we used double-stranded RNA duplexes with miRNA sequence 
that mimic miRNA function (Fig. 2 A; Hutvagner and Zamore, 
2002). Transfection of these duplexes into C2C12 reduced the 
luciferase expression when the cognate target site is placed 
at the 3′UTR of luciferase gene, validating the experimental 
  system. The cross-reactivity between miR-1 and -206 can be 
explained by their similar sequences. To ensure that the trans-
fected   miRNAs are not being assayed at supraphysiological 
levels, we measured the levels of miR-133 and -206 after trans-
fection into MBs and compared the levels of the same miRNA 
after induction of differentiation into MTs. The levels of the 
transfected miRNAs were comparable to the levels of the natu-
rally induced miRNAs (Fig. 2 B).
We began our studies with miR-206 because of the skele-
tal muscle–specifi  c expression of miR-206 (Fig. 1 A) and be-
cause of its similarity to miR-1. miR-206 transfection advanced 
MHC expression after changing to differentiation medium 
(DM; Fig. 2 C), whereas miR-133 did not (Fig. S1 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200603008/DC1) 
  under the same experimental condition.
Figure 1.  The muscle-speciﬁ  c expression of the miRNAs miR-1, -133, and 
-206. (A) RNase protection assays were performed with RNA from various 
tissues to detect miR-1, -206, and -133. 5S ribosomal RNA (rRNA) was 
used as a control. The different panels have different levels of exposure. 
The protected bands are indicated by arrows on the left. −, no RNA con-
trol; Co, colon; Kd, kidney; Ht, heart; Lv, liver; Bs, breast; Lu, lung; Si, small 
intestine; Sm, skeletal muscle; Ut, uterus; At, atrium; Sp, spleen; Te, testis; 
Ov, ovary; Bm, bone marrow; Br, brain; Cv, cervix; Pr, prostate tissue; Pt, 
prostate tumor; Pe, prostate epithelium. (B) During skeletal myogenesis of 
the C2C12 MB cell line, the miRNAs (bottom six panels) and several 
marker proteins for muscle differentiation (top four panels) were measured 
by RNase protection assays or immunoblots, respectively. The numbers at 
the bottom indicate the days after changing from GM to DM. In the immuno-
blot panels, molecular mass markers are indicated on the left and the myo-
genin band is speciﬁ  ed by an arrow. The panels for miR-1, -133, and -206 
are at comparable levels of exposure.MIR-206 IN MYOGENESIS • KIM ET AL. 679
Upon transfection in the continued presence of serum, miR-
206 markedly up-regulated the percentage of cells expressing 
MHC and the muscle-specifi  c transcription factor myogenin, rela-
tive to cells at comparable density transfected with GL2 control 
(Fig. 2, D and E; and Fig. S1, B and C). In addition, 28% of MHC-
positive cells are multinucleated after miR-206 treatment, whereas 
no multinucleated cells were detected in GL2 control (Fig. 2 D and 
not depicted). Therefore, physiological levels of miR-206 induce 
skeletal myogenesis from C2C12 even without serum depletion.
To measure the extent of differentiation and to extend the 
studies to the other muscle-specifi  c miRNAs, microarray exper-
iments were used to measure changes in global gene expression 
profi  le after muscle differentiation by serum deprivation (DM). 
The microarray profi  le after differentiation was compared with 
that obtained after miRNA transfection in the presence of serum 
(growth medium [GM]). We focused our analysis on the  100 
genes that were induced or repressed the most after C2C12 dif-
ferentiation to MTs by serum depletion (Fig. 2 F). Genes up- or 
down-regulated after muscle differentiation were changed simi-
larly by transfection of the miRNAs (in GM), with miR-206 
and -1 having similar effects and miR-133 affecting a slightly 
different subset of genes. Given the importance of the fi  rst eight 
nucleotides of miRNA in target interaction (Doench and Sharp, 
2004), the identical seed sequences between miR-1 and -206 
explain why the two miRNAs had almost identical changes in 
gene expression. These data suggest that the individual miRNAs 
change the repertoire of expressed genes in a direction mimick-
ing that seen during muscle differentiation. Further analysis of 
the microarray data will be addressed in the next section.
To determine whether the miRNAs were essential for dif-
ferentiation, C2C12 cells were treated with 2’-O-methyl anti-
sense oligonucleotides against the miRNAs (Hutvagner et al., 
2004; Meister et al., 2004) and then induced to differentiate by 
serum depletion. Inhibition of the miRNAs reduced the number 
of MHC-positive cells (Fig. 3, A and B) and decreased MHC 
levels in an immunoblot (Fig. 3 C), with little effect when only 
miR-133 was inhibited. BrdU immunostaining shows that a sig-
nifi  cant fraction of the cells remain in active DNA synthesis 
when the miRNAs are inhibited (42% for the anti-miR mix rela-
tive to 26% for the anti-GL2 control; P = 0.0071; Fig. 3, 
A and B). Inhibition of the miRNAs prevented the elongation of 
MTs seen during differentiation (Fig. 3 D). The cells remained 
relatively short and thick even after expression of MHC: 86% of 
MHC-positive cells in the anti-GL2 control sample were elon-
gated, as opposed to only 25% in the anti-miR mix sample. 
  Although inhibition of miR-1 and -206 (without inhibition of 
miR-133) was suffi  cient to decrease MHC expression and dere-
press DNA synthesis (Fig. 3 B), it was not suffi  cient to inhibit 
cell elongation (not depicted), suggesting that miR-133 might 
have specifi  c targets relevant to MT elongation. Collectively, 
the results suggest that the three miRNAs are required for com-
plete differentiation to muscle, with miR-206 (and miR-1) be-
ing particularly important for induction of cell quiescence.
Muscle-speciﬁ  c miRNAs regulate many 
genes as direct targets, including DNA pol 𝗂
Unlike plant miRNAs, animal miRNAs are believed to   repress 
protein synthesis without changing mRNA levels. Yet, the 
Figure 2.  The muscle-speciﬁ   c miRNAs in-
duce the differentiation of MBs by regulating 
many genes.  (A) Synthetic oligonucleotides 
complementary to miR-1, -133, and -206 were 
inserted downstream of Renilla luciferase ORF 
in pRL-CMV(MCS) to generate pRL1, pRL133, 
and pRL206, respectively. Luciferase assays 
were performed with pRL1 (white bar), pRL133 
(black bar), and pRL206 (hatched bar) with 
the cotransfected RNA duplexes mimicking the 
miRNAs miR-1, -133, and -206, respectively 
(x axis). Sequential transfection of each RNA 
duplex (or miR-125b duplex as a control) and 
reporter plasmids in GM (serum+) was fol-
lowed by luciferase assays 20 h after trans-
fection. The y axis indicates relative Renilla 
luciferase activity, which is normalized as de-
scribed in Materials and methods. (B) RNase 
protection assays were performed to measure 
the level of miR-133 (top) and -206 (middle), 
in MB transfected with the siRNA duplexes 
mimicking miR-133 or -206. 5S rRNA was 
used as a loading control (bottom). RNA from 
differentiated MTs is shown for comparison. 
(C) Immunoblots at the indicated days after the 
serum depletion of C2C12. C2C12 was trans-
fected four times at 24-h intervals with miR-206 
or GL2 negative control duplex before serum 
depletion. (D) C2C12 was transfected with miR-206 and GL2 as described in C, split at 5 × 10
5 cells per well in a 6-well plate, and maintained in GM 
(serum+) for 3 d before immunostaining for MHC. The density of the cells can also be gauged in Fig. S1 B (available at http://www.jcb.org/cgi/  content/
full/jcb.200603008/DC1). (E) Quantiﬁ  cation of MHC and myogenin expression in experiments as in D. MB, C2C12 MB in GM (serum+); MT, MT in DM 
(serum−); GL2 or 206, C2C12 in GM transfected with GL2 or miR-206 duplexes, respectively. Each value is a mean of triplicate. (F) Hierarchical cluster 
and heat map to show changes in mRNA relative to MBs in GM. Red and green represent increase and decrease of expression, respectively. Each row 
represents a single gene in the microarray. MT indicates C2C12 differentiated by serum deprivation, and other rows show C2C12 in GM transfected with 
the indicated duplexes. The 109 or 92 genes most up- or down-regulated after muscle differentiation are shown.JCB • VOLUME 174 • NUMBER 5 • 2006  680
  microarrays (Fig. 2 F) revealed a large number of mRNA 
changes after miRNA introduction. A signifi  cant number of 
up-regulated genes included muscle-specifi   c genes such as 
myosin light chain (phosphorylatable, fast skeletal muscle), 
myosin light polypeptide 1, troponin T1 (skeletal, slow), tro-
ponin I (skeletal slow 1), myomesin 2, and titin (Schiaffi  no and 
  Reggiani, 1996; Table S1, available at http://www.jcb.org/cgi/
content/full/jcb.200603008/DC1). Because miRNAs are ex-
pected to be repressive, the up-regulation of genes is most likely 
due to indirect effects after the primary differentiation-inducing 
stimuli of the miRNAs.
In contrast, the list of down-regulated mRNAs (Fig. 2 F 
and Table S2, available at http://www.jcb.org/cgi/content/full/
jcb.200603008/DC1) might include direct targets of the   miRNAs 
if, as in plants, the miRNAs promote target RNA cleavage. To 
identify such direct targets, we intersected the list of genes 
down-regulated in the microarrays with the list of predicted 
genes with miRNA target sites (generated using the miRanda 
program [Enright et al., 2003]). We focused our analysis on 
miR-206 because of its similarity with miR-1 and its pro-
nounced effect on muscle differentiation and cell proliferation 
(Figs. 2 and 3). On this intersection list, we were pleased to 
fi  nd the largest subunit of DNA pol α (Pola1; available from 
GenBank/EMBL/DDBJ under accession no. NM_008892.1), 
the replicative polymerase expected to be very important for 
cell proliferation.
miR-206 alone is suffi   cient to decrease Pola1 at the 
mRNA and protein levels as early as 24 h after transfection 
(Fig. 4 A). During differentiation of MBs to MTs, Pola1 mRNA 
and protein were also decreased (Fig. 4 A). The Pola1 pro-
moter requires the activity of E2F, a transcription factor that 
is repressed by pRb during myogenesis (Kalma et al., 2001; 
Kitzmann and Fernandez, 2001), so we wondered how much 
of the down-  regulation of Pola1 mRNA during differentiation 
was dependent on miR-206. Antisense to miR-206 signifi  cantly 
delayed the down-regulation of Pola1 mRNA (Fig. 4 D). This 
result is in agreement with the increase of BrdU-positive cells 
and decrease of MHC-positive cells when miR-206 was in-
hibited by antisense oligonucleotide (Fig. 3). The antisense to 
miR-206 does not, however, completely block differentiation 
(Fig. 3 B). Therefore, residual inhibition of Cdk2 kinase, hypo-
phosphorylation of Rb, and repression of E2F probably account 
for the eventual repression of Pola1 in the presence of antisense 
to miR-206, albeit with delayed kinetics. Together, these results 
suggest that miR-206 is important for the early down-regulation 
of Pola1 during differentiation.
Pola1 has two potential target sites of miR-206 (Fig. 4 B; 
Fig. S5, available at http://www.jcb.org/cgi/content/full/jcb.
200603008/DC1; and see Fig. 7 A) in the 4991–5345 segment 
Figure 3.  Inhibition of the miRNAs by 2’-O-methyl antisense oligonucleo-
tides inhibits differentiation. (A) C2C12 cells transfected with antisense 
  oligonucleotide against GL2 or a mixture of antisense oligonucleotides 
against miR-1, -133, and -206 (anti-mix). Three transfections at 24-h inter-
vals in GM (serum+) were followed by serum depletion (DM). 96 h after 
serum depletion, MHC expression (green) and BrdU incorporation (red) 
were detected by immunostaining. Blue indicates nuclei stained by DAPI. 
(B) Quantiﬁ  cation of percentage of BrdU- and MHC-positive cells in sam-
ples prepared as described in panel A. Anti-(1+206) indicates a mixture 
of 2’-O-methyl antisense oligonucleotides against miR-1 and -206. Each 
value is a mean of triplicate. (C) Immunoblots at 48 and 96 h after serum 
depletion (DM). The transfection and induction of differentiation were per-
formed as described in A. (D) Cell morphology visualized by MHC immuno-
staining as described in A (top). Results are quantitated at the bottom. Cells 
that were elongated were twofold longer than proliferating C2C12. Each 
value is a mean of triplicate experiments.
Figure 4.  miR-206 directly down-regulates DNA pol 𝗂 during differentiation. 
(A) Northern hybridization (top) and immunoblots (bottom) for the largest 
subunit of DNA pol α (Pola1) at 24 and 96 h after transfection of the indi-
cated duplexes into C2C12 in GM (serum+). MB and MT are shown for 
comparison. (B) Two predicted target sites of miR-206 in the 3′UTR of 
Pola1. The nucleotide coordinate of Pola1 is based on the mouse Refseq 
(available from GenBank/EMBL/DDBJ under accession no. NM_008892.1). 
M1 and M2, mutated (bold italic) from the seed matches (bold), are indi-
cated. (C) Luciferase assays were performed to measure the effect of miR-
206 transfection, as described in Fig. 2 A. pRL206 indicates insertion of a 
perfectly complementary target of miR-206 downstream of the luciferase 
gene in pRL-CMV. DNA pol α (3985–4657) and (4991–5345) indicates 
insertion of the indicated regions of Pola1 mRNA (available from Gen-
Bank/EMBL/DDBJ under accession no. NM_008892.1), respectively. M1 
and M2 indicate 4991–5345 with point mutations in putative target se-
quences as described in B. (D) Northern blot of Pola1 (top) and its quantiﬁ  -
cation (bottom) after transfection of antisense oligonucleotide against 
miR-206 (open squares) or GL2 (closed squares) during C2C12 differentia-
tion as described in Fig. 3 A. The ethidium bromide staining of two rRNA 
bands is shown as loading control. Each band from Northern hybridiza-
tion was quantiﬁ  ed with ImageQuant 5.2 software and normalized to the 
total RNA amount from the intensity of 28S and 18S rRNA. The normalized 
value at day 0 was set at 1.MIR-206 IN MYOGENESIS • KIM ET AL. 681
of the 3′UTR. Fusion of a luciferase reporter to this segment 
rendered luciferase repressible by miR-206 (Fig. 4 C). The level 
of repression by cotransfected miRNAs is comparable to the 
two- to threefold repression by miRNAs in all published ex-
periments where a reporter gene is fused to naturally occurring 
target 3′UTRs (Krek et al., 2005; Lim et al., 2005; Yu et al., 
2005). As a negative control, no repression was seen upon in-
sertion of another part of the 3′UTR of Pola1 without any pre-
dicted target sites for miR-206 (DNA pol α 3985–4657). Point 
mutations in the target sites in pol α 4991–5345 revealed that 
the one encompassing nucleotides 5007–5029 (M1; Fig. 4, B 
and C; Fig. S5; and see Fig. 7 A) is necessary for the repres-
sion by miR-206, whereas the second site at 5090–5114 (M2) 
is not required. Therefore, miR-206 directly down-regulates 
Pola1 mRNA, a down-regulation that probably contributes to 
the prompt suppression of cell proliferation seen during differ-
entiation. Pola1 is similarly down-regulated by miR-1 but not as 
much by miR-133 (Fig. 4 A and Fig. S2). However, miR-206 is 
likely to be more important than miR-1 for this function during 
C2C12 differentiation because it is present at a much higher 
level than miR-1 (Fig. 1 B).
The introduction of miR-206 results 
in a reduction of DNA synthesis 
and, eventually, cell cycle arrest
We measured whether down-regulation of DNA synthesis is an 
early event after miR-206 introduction. In good agreement with 
the Pola1 decrease, DNA synthesis was signifi  cantly inhibited 
by 24 h after transfection of miR-206, eventually leading to a 
decrease in cell proliferation that became evident at 72 h (Fig. 5 A). 
Because cell cycle arrest is a critical step during muscle differ-
entiation, we wondered whether the DNA synthesis inhibition 
induced by miR-206 leads to the cell cycle arrest. Upon serum 
depletion of MBs to form MTs, the Cdk inhibitors p21 and p27 
are induced and Cdk2 kinase activity is decreased accompanied 
by a reduction in the amount of the faster moving form of the 
Cdk2 that is phosphorylated on its activating site, Threonine160 
(Fig. 5 B; Guo et al., 1995). miR-206 transfection induces p21 
and p27 as early as 24 h after transfection. The FACS profi  le for 
DNA content (Fig. 5 C) and the activity of Cdk2 kinase 
(Fig. 5 B), however, demonstrate that G1 accumulation is not 
evident at 24 h after transfection, even though DNA synthesis 
was already reduced signifi  cantly (Fig. 5 A). At 96 h after trans-
fection, the miR-206 transfected cells eventually accumulate in 
G1 with repressed Cdk2 activity (Fig. 5 B), consistent with a G1 
arrest (not depicted). Therefore, miR-206–mediated inhibition 
of DNA synthesis precedes the cell cycle arrest.
 Next, we tested whether cells synchronized in the cell cy-
cle responded to miR-206 with an arrest in G1. C2C12 cells 
were synchronized at the G1/S boundary by thymidine aphidi-
colin block (Fig. 5 D, middle). During the synchronization, we 
introduced miR-206 or GL2. Upon removal of aphidicolin, 
GL2-treated cells were released from G1 through the subse-
quent stages of the fi  rst cell cycle (2–8 h) and proceeded through 
the second cell cycle (8 h and later; Fig. 5 E). miR-206–treated 
cells were released into S phase with delayed kinetics (2–8 h), 
and the delay was even more marked in the second cell cycle 
(Fig. 5, D [bottom] and E [>8 h]). The time of second G1 
Figure 5.  Inhibition of DNA synthesis by 
the down-regulation of DNA pol 𝗂 promotes 
withdrawal from the cell cycle in the continued 
presence of serum. (A) DNA synthesis (top) 
and cell growth (bottom) were measured after 
the transfection of GL2 (white bar) or miR-206 
(black bar) duplexes into C2C12 MB in GM 
(serum+). The same assays were performed at 
4 d after serum depletion (MT; hatched bar) 
with a similar number of cells before serum 
depletion (MB; gray bar) for comparison. 
Each value is a mean of four values from two 
independent transfections. The x axis shows 
days after transfection, and the y axis shows 
 
3H-thymidine incorporation or absorbance at 
570 nm from the MTT assay. (B) Immunoblots 
as described in Fig. 4 A. Cdk2 kinase activity 
shows an autoradiogram of   phosphorylated 
histone H1 (see Materials and methods). 
(C) Propidium iodide staining for DNA content 
and FACS to determine the number of cells 
transfected with GL2 or miR-206. The percent-
age of cells in G1, S, and G2 at 24 h are 
calculated and plotted. (D) For synchroniza-
tion of cell cycle, cells were treated with 2 mM 
of thymidine for 8 h, released for 8 h, and 
treated with 2 μg/ml of aphidicolin for 8 h. 
During synchronization, miR-206 (bottom two 
right panels) or GL2 control duplex (left) was 
transfected at the onset of thymidine treatment 
and a second time at 4 h after release from 
thymidine. Propidium iodide–stained FACS 
proﬁ  les of arrested cells (0 h; middle) and cells at 12 h after release from aphidicolin (bottom) are shown, with that of asynchronous MBs (top) for 
  comparison. (E) The percentage of cells in S phase (y axis) is quantiﬁ  ed as described in C before (0 h) or at the indicated time points (x axis) after release 
from aphidicolin. Closed circles indicate GL2 transfected cells, and open circles indicate miR-206 transfected cells.JCB • VOLUME 174 • NUMBER 5 • 2006  682
(Fig. 5 E, 10–12 h) corresponds to 34–36 h after transfection. 
Because the kinetics of target repression after miR-206 trans-
fection is likely to be slow, it is entirely expected that the cell 
cycle effect is more marked as the cell proceeds through succes-
sive cell cycles.
Other targets of the miRNAs
Besides Pola1, we tried to fi  nd additional targets of miR-206 
by two approaches. First, we reasoned that inhibitors of dif-
ferentiation could be putative targets of the miRNAs. MyoR 
(musculin) and Id 1–3 antagonize the action of the bHLH (basic 
helix-loop-helix) myogenic transcription factors like MyoD, 
whereas Hedgehog-interacting protein (Hhip) inhibits a factor 
called Hedgehog that promotes differentiation (Chuang and 
McMahon, 1999; Puri and Sartorelli, 2000; Li et al., 2004). All 
these mRNAs were down-regulated after transfection of miR-
206 (Fig. 6, A and C; and Table S2). However, Id1-3 and MyoR 
are unlikely to be regulated directly by miR-206, as indicated 
by the failure of miR-206 to repress luciferase reporter fused to 
these genes in transient transfection assays (Fig. 6 B) and the 
absence of any predicted target site. Hhip has a predicted target 
site (Table S3, available at http://www.jcb.org/cgi/content/full/
jcb.200603008/DC1), but is also not a direct target of miR-206 
in the luciferase fusion assay (Fig. 6 D). Indirect repression of 
these inhibitors of differentiation upon introduction of miR-206 
into C2C12 cells indicates how the chain of events initiated by 
direct down-regulation of key targets by a miRNA can have a 
profound effect on the differentiation program.
The second approach to fi   nding direct targets was to 
focus on genes that were decreased in the microarrays af-
ter miRNA introduction and contained putative target sites in 
the 3′ UTR. These include a Rac1 interacting protein named 
  butyrate-  induced transcript 1 (B-ind1), brain-derived neuro-
trophic factor, the gap-junction protein connexin43 (Cx43), 
nuclear receptor coactivator 5, AMP activated protein kinase, 
Hhip, junction adhesion molecule 4, and an adiponectin-related 
protein expressed in microglia called monocyte-to-macrophage 
differentiation-  associated protein (Mmd). All of these mRNAs 
were decreased by normal differentiation and by transfection 
of the miRNA (Fig. 6 C). Although all of them have predicted 
target sites (Table S3), fusion to luciferase reporter reveals that 
only B-ind1, Cx43, and Mmd are direct targets of miR-206 like 
DNA pol α (Fig. 6 D).
Of the four direct targets, Pola1 has already been shown to 
be important for cell quiescence. B-ind1 might infl  uence dif-
ferentiation through its interaction with the G protein Rac-1. 
Down-regulation of B-ind1 mRNA was inversely related to the 
up-regulation of miR-206 during differentiation and was abro-
gated when miR-206 was inhibited by anti–miR-206 (Fig. 6 E). 
We do not have any evidence, however, that B-ind1 down-
  regulation is critical for differentiation. The known functions of 
Cx43 and Mmd do not suggest that their repression is critical 
for differentiation.
Mechanism for down-regulation 
of the target mRNAs by the miRNAs
Having confi  rmed a critical role of miR-206 in the down-
  regulation of at least two targets, Pola1 and B-ind1 mRNA 
(Figs. 4 and 6), we next turned our attention to the mechanism 
of the down-regulation. miRNAs, unlike siRNAs, are not per-
fectly matched to their targets and have been reported to repress 
their targets at the protein synthesis level (Olsen and Ambros, 
1999; Seggerson et al., 2002; Dugas and Bartel, 2004). Plant 
  miRNAs (for reviews see Kidner and Martienssen, 2005; Millar 
and   Waterhouse, 2005) and at least one animal miRNA (Yekta 
et al., 2004) with perfect match to the target mRNA induce 
cleavage of the target. Short RNAs have also been shown to 
alter the chromatin state and thus repress the transcription of 
some genes (for review see Lippman and Martienssen, 2004). 
As was the case for Pola1, the addition of B-ind1 mRNA 
Figure 6.  Examination of down-regulated 
genes from microarray to determine whether 
they are direct targets of miR-206. (A and C) 
Northern blots for MyoD inhibitors or down-
regulated genes containing putative miRNA 
targets, as described in Fig. 4 A. (B and D) 
The luciferase assays were performed with 
pRL-CMV derivatives containing the mRNA se-
quences of the genes in A and C, respectively, 
as described in Fig. 2 A. The difference from 
RL-CMV control is signiﬁ  cant for B-ind1 (P = 
0.0059), Cx43 (P = 0.06), and Mmd (P = 
0.0006). (E) Northern blot and quantiﬁ  cation 
of B-ind1 mRNA after transfection of antisense 
oligonucleotide during C2C12 differentiation, 
as described in Fig. 4 D. The level of miR-206 
during differentiation (of anti-GL2 transfected 
cells) was measured by RNase protection as-
says (top) and quantitated (bottom, ﬁ  lled  tri-
angle with dotted line).MIR-206 IN MYOGENESIS • KIM ET AL. 683
  sequence downstream from a luciferase reporter confers sup-
pression by miR-206, suggesting that B-ind1 is a direct target 
of miR-206 (Fig. 7 C). Point mutations indicate that at least two 
predicted target sites contribute to the down-regulation (Fig. 7, 
A, B, and C, M1 and M2; and Fig. S3, available at http://www.
jcb.org/cgi/content/full/jcb.200603008/DC1).
Nuclear run-on experiments were performed to determine 
whether there is any transcriptional repression of these direct 
target genes induced during differentiation or after introduction 
of miRNAs miR-1 or -206. Transcriptional activity of Pola1 was 
too low to be measured by nuclear run-on (unpublished data), 
but that of B-ind1 was measured and found to not decrease 
after C2C12 differentiation or after the introduction of miR-1 
and -206 (Fig. 7 D). The Northern blots that accompanied this 
experiment show that the steady-state mRNA level of B-ind1 
is repressed by at least fi  vefold (Fig. 7 D), suggesting that the 
miRNAs repress B-ind1 at the posttranscriptional level.
To test if the posttranscriptional reduction is due to the 
cleavage of mRNA by the miRNAs, we performed modifi  ed 
rapid amplifi  cation of cDNA ends (RACE)–PCR (Llave et al., 
2002) to map the 5′ ends of potential cleavage fragments of 
B-ind1 and Pola1. Differentiated MTs (not depicted) and 
C2C12 MBs transfected with miR-206 and -1 (Fig. 7, E and F) 
generated more cleavage products from the B-ind1 transcript 
compared with the MBs or cells transfected with either GL2 
control or miR-133. Similar results were obtained from Pola1 
(unpublished data), supporting the hypothesis that the mRNAs 
are cleaved in the presence of the miRNAs. The sizes of RACE-
PCR products derived from the B-ind1 (Fig. 7 E) or Pola1 
(not depicted) after transfection of miR-206 are distinct from 
those obtained after transfection of miR-1 (Fig. 7 E and 
Fig. S3). As miR-1 and -206 recognize similar target sites and 
similarly decreased B-ind1 (Fig. 7 D), the different cleavage 
sites between the two miRNAs suggest that the miRNAs do not 
select the cleavage sites. To support this idea, sequencing of the 
RACE-PCR products revealed that the 5′ ends of cleavage frag-
ments mapped at multiple sites in the B-ind1 mRNA (Fig. 7 A 
and Fig. S3) and were not confi  ned to putative target sites of 
miR-206. B-ind1 mRNA was cleaved similarly during differ-
entiation (Fig. S4, available at http://www.jcb.org/cgi/content/
full/jcb.200603008/DC1). DNA pol α mRNA was cleaved by 
transfection of miR-206, and these cleavage sites also did not 
match with putative target sites (Fig. 7 A and Fig. S5). In con-
trast, siRNAs cleave the target mRNA at the center of RNA du-
plex by RISC (RNA-induced silencing complex; Elbashir et al., 
2001b; Yekta et al., 2004). A control experiment with miR-206 
siRNA against a perfectly matching site in luciferase 3′UTR 
showed that cleavage in this case was exactly at the siRNA tar-
get site (unpublished data). Thus, although the down-regulation 
of B-ind1 and Pola1 mRNA depends on miR-206 target sites 
with multiple mismatches and bulges, and although the target 
mRNA is cleaved, the 5′ ends of the cleavage fragments are 
distributed and do not match the target sites.
Discussion
We show that miRNAs not only promote differentiation of MBs 
in vitro but are required for differentiation. Individual miRNAs 
Figure 7.  The down-regulation of direct tar-
gets by miR-206 is posttranscriptional, depen-
dent on target sites, and occurs through mRNA 
cleavage. (A) The schematic of B-ind1 mRNA 
(top) and 3′UTR of Pola1 mRNA (bottom). 
  Vertical bars show potential binding sites of 
miR-206, predicted by miRanda program (∆g is 
less than −14 kcal/mol). M1 and M2 indicate 
point mutations at indicated sites (used in C 
and Fig. 4 C and described in B and Fig. 4 B). 
P, P1, and P2 indicate locations of each set of 
primers for the RACE-PCR (used in E and F and 
Figs. S3–S5, available at http://www.jcb.org/
cgi/content/full/jcb.200603008/DC1). Cleav-
age sites for each treatment are indicated as 
described in the ﬁ  gure (see also Figs. S3  –S5). 
The number of arrowheads corresponds to the 
frequency of cloning from RACE-PCR product. 
Although MB had very few cleavage products 
(E), we cloned a few to show that distribution 
of background cleavage sites is different from 
that seen in the presence of miRNAs (Fig. S4). 
(B) Among the several predicted target sites 
(A) of miR-206 in B-ind1 mRNA (available 
from GenBank/EMBL/DDBJ under accession 
no.NM_021345), two sites are shown as 
described in Fig. 4 B. (C) Luciferase assays 
were performed as described in Fig. 4 C, with 
pRL-CMV derivatives containing B-ind1 3′UTR 
without mutation (B-ind1 wild type [wt]) or with 
point mutations at both M1 and M2 (B-ind1 M1/M2; described in B). (D) Nuclear run-on assays to measure the transcription of B-ind1 and GAPDH upon 
differentiation (MB vs. MT) or after transfection of the indicated duplexes in GM (serum+). PBS, pBluescript vector negative control. (E) Agarose gel electro-
phoresis of RLM-RACE products from primer set P1 (A and Fig. S5 A), showing sites of cleavage of B-ind1 mRNA from C2C12 transfected with indicated 
duplexes in GM (serum+). Molecular size markers (in nucleotides) are indicated. (F) Quantitation of the amount of the RLM-RACE products from E as 
described in Materials and methods. The x axis indicates the relative intensity. Each value is a mean of triplicate measurements.JCB • VOLUME 174 • NUMBER 5 • 2006  684
like miR-206 produce large changes in gene expression at the 
mRNA level that mimic changes seen upon differentiation, and 
the down-regulation of a direct target of miR-206, Pola1, might 
contribute to the cell cycle quiescence upon differentiation. 
In addition, several inhibitors of myogenic transcription factors 
are repressed after miR-206 transfection, leading to further am-
plifi  cation of the prodifferentiation function. At least two of the 
direct targets are cleaved at the posttranscriptional level, but the 
5′ ends of the cleavage fragments suggest the involvement of ex-
onucleases, a fi  nding that has implications for the proposed in-
volvement of processing bodies (P-bodies) in miRNA   function. 
Finally, we describe an effi  cient strategy for identifying direct 
targets of miRNAs by intersecting mRNAs down-regulated by 
miR-206 in microarray screens with computationally predicted 
targets and then checking the intersection list by transient trans-
fection and luciferase fusion assays.
Transfection of miR-1 in a nonmuscle cell has been re-
ported to alter the gene expression profi  le toward that of muscle 
(Lim et al., 2005), but there was no indication of the magnitude 
of the change or the importance of the miRNAs in the physiol-
ogy of muscle differentiation. Our results suggest that muscle-
specifi  c miRNAs promote skeletal myogenesis through direct 
down-regulation of several target genes and are required for nor-
mal differentiation. The microarray result indicates that the gene 
expression changes effected by miR-206 or -1 are closer to that of 
normal differentiation compared with that effected by miR-133. 
Because miR-206 is specifi  cally expressed in skeletal muscle, 
whereas miR-1 is present in both skeletal and cardiac muscle, it 
would be interesting to compare miR-206 and -1 in greater detail 
to identify overlapping or unique roles in myogenesis.
A block to DNA synthesis through the direct down-
  regulation of DNA pol α precedes the cell cycle withdrawal and 
is the fi  rst demonstration of miRNAs directly affecting DNA 
replication. This result is supported by the recent observation 
that overexpression of miR-1 decreased the pool of  proliferating 
ventricular cardiomyocytes in transgenic mice (Zhao et al., 
2005). It is not clear yet whether down-regulation of the three 
other targets identifi  ed, B-ind1, Cx43, and Mmd, contributes in 
any way to the muscle differentiation program. To fully under-
stand the role of miR-206 in skeletal myogenesis, we expect to 
uncover more targets of the miRNA in the future.  Combinatorial 
down-regulation of multiple targets may be necessary to fully 
mimic the effect of miR-206 transfection into MBs.
miR-135b, -338 (Wienholds et al., 2005), and -181 
(  Naguibneva et al., 2006) are also muscle specifi  c, suggesting 
that there may be additional miRNA involved in the regulation 
of myogenesis. miR-181 (Naguibneva et al., 2006), -1, and -133 
(Chen et al., 2006) have already been shown to play a role in 
muscle differentiation by repressing their cognate targets, and 
our results add miR-206 to the list. We expect that extensive co-
operation between several miRNAs and several transcription fac-
tors is necessary to effect the complete differentiation program.
The mode of action of miRNAs is still being debated. The 
multiple mismatches with target sites are believed to prevent 
cleavage of the target by a siRNA-like mechanism. Our results 
indicate, however, that at least for four endogenous targets, the 
repression by a miRNA is accompanied by a decrease in mRNA 
levels. For one of these direct targets (B-ind1), we rule out any 
transcriptional component, and for two of them (B-ind1 and 
Pola1), we show that the repression is accompanied by genera-
tion of mRNA cleavage fragments with multiple 5′ ends that do 
not map to the essential target sites matching the miRNA 
 sequence.  The  exact  5′ ends vary and do not overlap when 
B-ind1 is down-regulated by the transfection of miR-206 or -1 
or serum deprivation. This variability of the 5′ ends of the cleav-
age fragments suggests that they may be created by exonuclease 
activity after an initial endonucleolytic cleavage. RNA P-bodies 
have recently been proposed as sites where miRNAs sequester 
their target mRNAs from the protein-synthesis machinery (Liu 
et al., 2005; Sen and Blau, 2005). P-bodies contain exonucle-
ases, so that the degradation of target mRNAs observed in this 
paper could be the end stage of the sequestration of targets in 
  P-bodies. By serving as a common platform for both processes, 
P-bodies might explain how miRNAs can in some cases repress 
protein levels but not mRNAs and in other cases promote the 
degradation of mRNAs. An important point is that changes 
in mRNA profi  le during differentiation, thought to be mainly 
the province of transcription factors, can also be dictated by 
miRNA-mediated posttranscriptional cleavage of mRNAs.
The approach described here of intersecting mRNAs dis-
covered to be down-regulated in microarray screens after miRNA 
transfection with mRNAs that have computationally predicted 
matches to miRNAs provides a high yield of potential targets. 
Fusion of candidate 3′UTRs to luciferase can then be used to 
quickly narrow down the list of targets to those that are directly 
down-regulated by miRNAs. Combining this strategy with 
in vitro differentiation systems is likely to yield many miRNA 
targets critical for differentiation down specifi  c lineages. We 
are aware, of course, that this strategy might overlook targets 
that are exclusively down-regulated at the protein level, such 
as HoxA11 by miR-181 (Naguibneva et al., 2006) and histone 
deacetylase by miR-1 (Chen et al., 2006). If, however, down-
regulation of protein synthesis by miRNAs involves sequestra-
tion of the target mRNAs to P-bodies, we suspect that many 
direct targets of miRNAs will eventually be down-  regulated at 
the mRNA level and thus be revealed in the microarray screens. 
Because different computational algorithms predict different 
sets of targets for a given miRNA, a future extension of this 
work will be to intersect the microarray data with the output 
from other target prediction programs.
The ability of miRNAs to affect many mRNAs is similar 
to the ability of transcription factors to regulate many promot-
ers simultaneously. Thus, just like transcription factors, we pre-
dict that miRNAs will induce complex changes in rate-limiting 
steps of cell metabolism and thus have a profound effect on the 
differentiation program. An additional point of interest is the inter-
action between these miRNAs and transcription factors known 
to be involved in muscle differentiation. For example, MyoD has 
already been suggested to be involved in the induction of miR-1 
in cardiac myogenesis (Zhao et al., 2005). We suggest here that 
one of the muscle-specifi  c miRNAs, miR-206, indirectly down-
regulates Id1-3 and MyoR, inhibitors of myogenic transcription 
factors like MyoD. Such a positive feedback loop between the 
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will be expected to push the equilibrium toward differentiation 
and could be very signifi  cant for holding muscle cells in a per-
manently differentiated state.
Materials and methods
Cell culture
C2C12 (American Type Culture Collection; Yaffe and Saxel, 1977) mouse 
skeletal MBs were maintained at subconﬂ   uent densities in DME supple-
mented with 20% FCS (GM). Myogenic differentiation (Andres and Walsh, 
1996) into MT was induced by changing subconﬂ  uent cells to DME con-
taining 2% heat-inactivated horse serum (DM).
Antibodies
Antibodies to p21 (C-19), p27 (C-19), Cdk2 (M2), Cdk4 (C-22), Pola1 
(G-16), and myogenin (mouse mAb F5D) were purchased from Santa Cruz 
Biotechnology, Inc. Mouse mAb against MHC and anti–β-actin antibody 
were obtained from Sigma-Aldrich.
RNA oligonucleotides and transfection
Double-stranded RNA oligonucleotides containing on one strand the 
sequences of miR-1 (5′-uggaauguaaagaaguaugua-3′), -133 (5′-uuggu-
ccccuucaaccagcugu-3′), -206 (5′-uggaauguaaggaagugugugg-3′), and 
-125b (5′-ucccugagacccuaacuuguga-3′), as well as GL2 (Elbashir et al., 
2001a) were synthesized by Invitrogen. Complementary sequence of 
each oligonucleotide was designed to produce a two-nucleotide over-
hang at both the 3′ ends of the duplex.
2’-O-methyl antisense oligonucleotides against miR-1, -133, and -206 
and GL2 were synthesized by Dharmacon RNA Technologies. Transfection 
into C2C12 was performed with Lipofectamine 2000 reagent (Invitrogen), 
combined with 267 nM of each siRNA duplex or with 133 nM of 2’-O-methyl 
antisense oligonucleotide.
Immunostaining
Immunostaining was performed as described previously (Andres and 
Walsh, 1996). Unless otherwise speciﬁ  ed, all manipulations were at room 
temperature. Cells on sterile glass coverslip were ﬁ  xed with 2% formalde-
hyde in PBS for 15 min and were permeabilized with 0.2% Triton X-100 
and 1% normal goat serum (NGS) in ice-cold PBS for 5 min. After blocking 
with 1% NGS in PBS two times for 15 min, incubation with primary anti-
body (1:400 in 1% NGS) for 1 h was followed by the FITC-conjugated 
anti–mouse IgG (dilution 1:500; DakoCytomation) for 1 h. Control experi-
ment with H-3 (anti-hexahistidine) as a primary antibody ensured no cross-
reactivity of the secondary antibodies. In case of sequential anti-BrdU 
probing, the above steps are repeated, but treatment with 1.5 N HCl for 
30 min was included before the incubation with Alexa Fluor 594–
  conjugated anti-BrdU (Invitrogen) antibody (1:100 in 1% NGS) for 1 h. 
  After washes, nuclei were counterstained with DAPI (H-1200; Vector Labo-
ratories) for 1 min before mounting. Images were visualized using a micro-
scope (Microphot-SA; Nikon) with 60× magnitude, captured using a 
camera (UFX-DX; Nikon), and processed using SPOT (version 3.5.4 for 
MacOS; Diagnostic Instruments) software.
Cdk2 kinase assays
50 μg of protein was immunoprecipitated with anti-Cdk2 antibody over-
night and then pulled down on protein G–Sepharose beads for 2 h. The 
beads were washed three times with lysis buffer (50 mM Tris, pH 7.4, 
150 mM NaCl, 0.1% NP-40, 5 mM EDTA, 50 mM NaF, 1 mM sodium 
vanadate, and protease inhibitors) and twice with kinase buffer (50 mM 
Hepes-NaOH, pH 7.4, and 25 mM MgCl2). The beads were then incu-
bated with 25 μl kinase reaction mixture (50 mM Hepes-NaOH, pH 7.4, 
25 mM MgCl2, 0.5 mM DTT, 50 μM ATP, 5 μCi γ-[
32P]ATP, and 2 μg 
  histone H1). The reactions were incubated at 30°C for 30 min and stopped 
by the addition of 12.5 μl of 3× SDS sample buffer.
Cell proliferation assay and measurement of DNA synthesis
Cell growth was measured with CellTiter 96 nonradioactive cell prolifera-
tion assay kit (Promega). DNA synthesis was measured as described previ-
ously (Busino et al., 2003) with minor modiﬁ  cations. Cells were treated 
with 1 μCi of methyl-[
3H]thymidine in 0.25 ml of medium in a 24-well dish. 
Incubation at 37°C for 1 h was followed by washing with PBS two times. 
Radioactively labeled cells were treated with ice-cold stop solution contain-
ing 10% (vol/vol) TCA and 0.2 M sodium pyrophosphate for 20 min, 
washed in 95% ethanol two times, and solubilized in 1% (vol/vol) SDS 
and 10 mM NaOH. Solubilized samples were transferred onto paper 
(3MM; Whatman) and dried under an infrared lamp. The radioactivity 
was measured with a liquid scintillation counter.
RNA isolation and RNase protection assay
Total RNA was isolated with Trizol reagent (Invitrogen) according to the 
manufacturer’s instructions. Total RNAs from human atrium, breast, brain, 
colon, cervix, heart, kidney, lung, ovary, prostate tumor, prostate, spleen, 
small intestine, skeletal muscle, testis, and uterus were purchased from 
  Ambion, and total RNA from human bone marrow was purchased from 
CLONTECH Laboratories, Inc.
RNase protection assay was performed with miRNA detection kit 
(Ambion) with minor modiﬁ  cations. 20 μl of reaction contained the indi-
cated amount of RNA, 0.6 μg of yeast tRNA, and the probe RNA, which 
was in vitro transcribed, labeled with α-[
32P]UTP using miRNA probe con-
struction kit (Ambion), and puriﬁ   ed from polyacrylamide gel. Digestion 
products were resolved by electrophoresis in an 18% polyacrylamide gel 
with 7 M urea.
Microarray
C2C12 cells (MB) were induced to MT or were transfected six times at 24-h 
intervals with GL2 or miR-1, -133, or -206, respectively. Total RNAs from 
each sample were isolated on day 7 by using Trizol reagent. Subsequent 
steps for the hybridization to Affymetrix GeneChip Mouse Genome 430 
2.0 Array (containing  45,000 transcripts) were done according to 
  standard Affymetrix protocols. The array data were analyzed with the 
GeneChip Operating Software. The varied genes were identiﬁ  ed by com-
paring the two samples in fold change and/or “present” and “absent” 
calls. The results of the microarray screen can be found on Gene Expres-
sion Open Source System (https://genes.med.virginia.edu/public_data/
index.cgi) and are freely available to the public.
Nuclear run-on assay
For nuclear run-on assay, 0.5 μg of each DNA fragment was slot blotted 
onto a positively charged Nylon membrane (Nytran; Schleicher & Schuell). 
Nucleus isolation and run-on transcription reaction were performed as 
  described previously (Greenberg and Bender, 2002) with modiﬁ  cations. 
  After the transcription reaction, Trizol reagent was added, and RNA probe 
was prepared according to the manufacturer’s instructions. Membranes 
were probed with 
32P-labeled run-on RNA for 16 h at 68°C in hybridiza-
tion buffer containing 0.25 M Na2HPO4, pH 7.2, 1 mM EDTA, and 7% 
(wt/vol) SDS. Membranes were washed twice in 2× SSC at room tempera-
ture for 15 min each, followed by a wash in 0.2× SSC and 1% (wt/vol) 
SDS at 65°C for 20 min.
RACE-PCR (RNA ligase-mediated [RLM]–PCR)
To map the cleavage sites of B-ind1 and Pola1 mRNA, RLM-PCR was per-
formed with GeneRacer kit (Invitrogen) with modiﬁ   cations (Llave et al., 
2002). Total RNAs from C2C12 cells transfected with GL2 or with miR-206 
were ligated with RNA adaptor without any pretreatment (Yekta et al., 
2004). B-ind1– or Pola1-speciﬁ  c primers for the cDNA synthesis, the ﬁ  rst-
round PCR, and the second-round PCR are indicated in Figs. S3, S4, and S5. 
The PCR products were separated on 1.1% agarose gel. Each lane on the 
agarose gel was quantiﬁ  ed with ImageQuant 5.2 software and normal-
ized to the B-ind1 mRNA level in the input mRNA. Titration of input mRNA 
ensured that the amount of RLM-RACE PCR product in a given sample is 
proportional to the input mRNA. The PCR products were subcloned into 
PCR4-TOPO vector and sequenced.
Luciferase reporter assays
For ease of subsequent subcloning, pRL-CMV(MCS) was modiﬁ  ed from the 
original vector pRL-CMV (Promega) by inserting a synthetic linker with vari-
ous restriction sites into the XbaI restriction site downstream of the ORF of 
Renilla (Renilla reniformis) luciferase gene.
At 20 h after transfection of the miRNAs and the luciferase plasmids 
into C2C12 cells, luciferase assays were performed with Dual-  luciferase 
reporter assay system (Promega) per the manufacturer’s instructions. 
  Luminescent signal was quantiﬁ  ed by luminometer (Monolight 3020; BD 
Bio  sciences). Each value from Renilla luciferase construct (Rr) was ﬁ  rst nor-
malized to the ﬁ  reﬂ  y (Photinus pyralis) luciferase assay value (Pp) from the 
cotransfected pGL3-control vector (Promega). Each Rr/Pp value was again 
normalized to the Rr/Pp value from miR-125b as a control. Each value is a 
mean of three transfections.
The luciferase constructs containing various putative target genes 
  include B-ind1 (1248–2334 of accession no. NM_021345.1, available 
from GenBank/EMBL/DDBJ), brain-derived neurotrophic factor (700–1756 JCB • VOLUME 174 • NUMBER 5 • 2006  686
of accession no. NM_007540.3), Cx43 (82–2700 of accession no. 
BC006894), Hhip (800–2982 of accession no. NM_020259.3), junction 
adhesion molecule 4 (91–1491 of accession no. NM_028078.1), and 
Mmd (301–2510 of accession no. NM_026178.2). The indicated regions 
were PCR ampliﬁ  ed and inserted into pRL-CMV.
Online supplemental material
Fig. S1 shows an examination of muscle markers and cell density after 
transfection of the miRNAs. Fig. S2 shows that miR-1, but not -133, directly 
down-regulates DNA pol α through the M1 site. Figs. S3, S4, and S5 show 
cleavage sites on B-ind1 or Pola1 mRNA. Tables S1 and S2 show the 30 
most up- and down-regulated genes, respectively, in C2C12 transfected 
with miR-206 duplex. Table S3 shows that the potential target sequences 
for miR-206, predicted by miRanda, exist in several putative target genes. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200603008/DC1.
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